In vitro, a GRPR inhibitor reduced cell proliferation, inhibited DNA synthesis, and caused cell cycle arrest at the G2/M phase, reversing the aggressive character of the human neuroblastoma cell line BE(2)-C [347]. This evidence concerns the gene GRPR and neuroblastoma.